Yong Zou

Yong Zou

Auto-generated profile, based on publicly available information

Yong Zou

Department of Traditional Chinese Medicine, Changhai Hospital, Second Military Medical University, Shanghai 200433, China

Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 April 2019 in Evidence-Based Complementary and Alternative Medicine
Verified
Journal Article
Open access
PDF file
QCQunwei Chen
Qunwei Chen
WLWanfu Lin
Wanfu Lin
ZYZifei Yin
Zifei Yin
YZYong Zou
Yong Zou
SLShufang Liang
Shufang Liang
CLChangquan Ling
Changquan Ling
In this study, we investigated whether melittin could suppress hypoxia-induced vasculogenic mimicry (VM) formation in liver cancer and explored the underlying mechanisms. Melittin significantly inhibited the proliferation of liver cancer cells with or without CoCl2presence. Melittin also significantly inhibited CoCl2-induced migration, invasion, and VM formation of liver cancer cells. CoCl2treatment suppressed the expression of E-cadherin and elevated the expression of N-cadherin and Vimentin. Melittin reversed the changes in the protein and mRNA levels of these epithelial-mesenchymal transition (EMT) markers. CoCl2-induced accumulation of HIF-1αincreased the level of phosphorylated Akt and upregulated the expression of VEGF and MMP-2/9. Melittin decreased the HIF-1αlevel and thereby suppressed the levels of p-Akt, VEGF, and MMP-2/9. In addition, the inhibitor of PI3K/Akt also suppressed CoCl2-induced EMT and liver cancer cells migration, and the activator of Akt, SC-79, partly blocked the effect of melittin on CoCl2-induced EMT and liver cancer cells migration. In the xenograft tumor model in nude mice, melittin treatment significantly suppressed the tumor growth, VM formation, and HIF-1αexpression in the tumor. In conclusion, this study indicates melittin may inhibit hypoxia-induced VM formation and EMT in liver cancer through inhibiting HIF-1α/Akt pathway.

2 July 2012 in Journal of Hematology & Oncology
Verified
Journal Article
Open access
PDF file
YZYong Zou
Yong Zou
XMXudong Ma
Xudong Ma
YHYiqun Huang
Yiqun Huang
LHLingling Hong
Lingling Hong
JCJen-Wei Chiao
Jen-Wei Chiao
Background: We have previously studied the histone acetylation in primary human leukemia cells. However, histone H3 methylation in these cells has not been characterized. Methods: This study examined the methylation status at histone H3 lysine 4 (H3K4) and histone H3 lysine 9 (H3K9) in primary acute leukemia cells obtained from patients and compared with those in the non-leukemia and healthy cells. We further characterized the effect of phenylhexyl isothiocyanate (PHI), Trichostatin A (TSA), and 5-aza-2’-deoxycytidine (5-Aza) on the cells. Results: We found that methylation of histone H3K4 was virtually undetectable, while methylation at H3K9 was significantly higher in primary human leukemia cells. The histone H3K9 hypermethylation and histone H3K4 hypomethylation were observed in both myeloid and lymphoid leukemia cells. PHI was found to be able to normalize the methylation level in the primary leukemia cells. We further showed that PHI was able to enhance the methyltransferase activity of H3K4 and decrease the activity of H3K9 methyltransferase. 5-Aza had similar effect on H3K4, but minimal effect on H3K9, whereas TSA had no effect on H3K4 and H3K9 methyltransferases. Conclusions: This study revealed opposite methylation level of H3K4 and H3K9 in primary human leukemia cells and demonstrated for the first time that PHI has different effects on the methyltransferases for H3K4 and H3K9.

1 January 2018 in Evidence-Based Complementary and Alternative Medicine
Verified
Journal Article
Open access
SLShufang Liang
Shufang Liang
YZYong Zou
Yong Zou
JGJingdong Gao
Jingdong Gao
XLXiaolin Liu
Xiaolin Liu
WLWanfu Lin
Wanfu Lin
CLChangquan Ling
Changquan Ling
Hepatocellular carcinoma (HCC) is one of the most common malignant tumors worldwide. In China, traditional Chinese herb medicine has been widely used in the treatment of HCC. Jiedu Recipe (JR) is a common used prescription which has shown good results against HCC. However, the exact mechanisms of JR are still unknown. Therefore, we investigated the efficacy of JR on HCC in the current study. JR inhibited the cell viability of both SMMC‐7721 and Huh7 cells in both time‐ and dose‐dependent manners. Transwell assay revealed that JR decreased the number of migrated cells of SMMC‐7721 cells. JR treatment increased the E‐cadherin expression level and decreased the levels of p‐Smad2/3 and Smad2/3. Further study showed that JR reversed the effect of TGFβ1 on the expression of E‐cadherin, vimentin, N‐cadherin, and MMP2/9. JR also significantly inhibited TGFβ1‐induced migration and invasion of SMMC‐7721 and Huh7 cells determined by wound healing assay and transwell assay. TGFβ1 treatment increased the phosphorylation of Smad2/3, p38 MAPK, JNK, ERK1/2, and Akt in SMMC‐7721 cells and pretreatment with JR blocked TGFβ1‐induced activation of Smad2/3 and Akt and MAPKs. In conclusion, JR inhibits liver cancer cells migration and invasion through epithelial mesenchymal transition (EMT) inhibition via Smad2/3 dependent and independent pathways, suggesting it is an effective therapeutic strategy against HCC metastasis.

19 May 2022 in Evidence-Based Complementary and Alternative Medicine
Verified
Journal Article
Open access
PDF file
SLShufang Liang
Shufang Liang
YZYong Zou
Yong Zou
JGJingdong Gao
Jingdong Gao
XLXiaolin Liu
Xiaolin Liu
WLWanfu Lin
Wanfu Lin
CLChangquan Ling
Changquan Ling
[This corrects the article DOI: 10.1155/2018/5629304.].

1 May 2023
Verified
Conference Paper
Closed access
MKMichael Nolan Kammer
Michael Nolan Kammer
SZSifang Kathy Zhao
Sifang Kathy Zhao
HMHidetoshi Mori
Hidetoshi Mori
YZY. Zou
Y. Zou
SDS. Deppen
S. Deppen
FMF. Maldonado
F. Maldonado

15 June 2022 in Cancer Research
Verified
Journal Article
Open access
MSMaria-Fernanda Senosain
Maria-Fernanda Senosain
YZYong Zou
Yong Zou
KPKhushbu Patel
Khushbu Patel
VPVera Pancaldi
Vera Pancaldi
CLCarlos F. Lopez
Carlos F. Lopez
PMPierre P. Massion
Pierre P. Massion
Lung adenocarcinoma (ADC) is a heterogeneous group of tumors associated with different survival rates, even when detected at an early stage. Here, we aim to investigate the biological determinants of early ADC indolence or aggressiveness using radiomics as a surrogate of behavior. We present a set of 93 ADC patients with data collected across different methodologies. Patients were risk-stratified using the Computed Tomography-Based Score Indicative of Lung Cancer Aggression (SILA) tool (continuous score from 0 to 1, 1 being the highest). We grouped the patients as indolent (x <= 0.4, n=14), intermediate (0.4 > x <= 0.6, n=27) and aggressive (0.6 > x <= 1, n=52). Using CyTOF we identified epithelial, mesenchymal, and immune subpopulations characterized by high HLA-DR expression that were associated with indolent behavior. In the RNA-Seq dataset, pathways related to immune response were downregulated in aggressive tumors compared to indolent while pathways associated with cell cycle and proliferation were upregulated. Pathways associated with structural cellular components, epithelial-mesenchymal transition (EMT), and extracellular matrix organization were upregulated in indolent and aggressive when compared to intermediate. We used HealthMyne (HM) software to extract radiomics features from the CT scans of the patients and computed pairwise correlation with SILA to select significant variables. For the data integration step, we selected features that were significantly associated with SILA from the datasets described above. Features’ and patients’ clusters were obtained by hierarchical clustering (k=4). Feature cluster “a” (FC-a) was composed by proteomics and transcriptomics features associated with immune response, antigen presentation, HLA-DR protein expression and HM features negatively associated with SILA, such as percent of ground glass opacity; FC-b was composed by HM features positively associated with SILA, an epithelial cell subset negative for HLA-DR; FC-c was composed by pathways associated with structural cellular components and EMT; FC-d was composed by pathways associated with DNA replication, proliferation and cell cycle. Patients from patient cluster 4 (PC-4) were all aggressive and were high for FC-d, mid for FC-b and FC-c and low for FC-a; Patients from PC-2 were a mix of indolent, intermediate and aggressive and were high for FC-a, low for FC-d and FC-b and a fractioned low/high for FC-c; PC-3 and PC-1 patients were a mix of intermediate and aggressive and the former showed mid signal for FC-b and FC-c and low for FC-a and FC-d while the latter showed low signal for all FCs. PC-4 patients did significantly worst in progression and recurrence free survival compared to all other PCs and to PC-1 alone. In conclusion, we found a bridge between radiomics and tumor biology which could improve the discrimination between indolent and aggressive ADC tumors. Citation Format: Maria-Fernanda Senosain, Yong Zou, Khushbu Patel, Vera Pancaldi, Carlos F. Lopez, Pierre P. Massion. Multi-omics data integration of early lung adenocarcinoma reveals an association between radiomics features and tumor biology [abstract]. In: Proceedings of the American Association for Cancer Research Annual Meeting 2022; 2022 Apr 8-13. Philadelphia (PA): AACR; Cancer Res 2022;82(12_Suppl):Abstract nr 2702.